JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M508628200 on October 21, 2005

J. Biol. Chem., Vol. 280, Issue 51, 42026-42035, December 23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/51/42026    most recent
M508628200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panov, A.
Right arrow Articles by Greenamyre, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panov, A.
Right arrow Articles by Greenamyre, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Rotenone Model of Parkinson Disease

MULTIPLE BRAIN MITOCHONDRIA DYSFUNCTIONS AFTER SHORT TERM SYSTEMIC ROTENONE INTOXICATION*

Alexander Panov{ddagger}1, Sergey Dikalov§, Natalia Shalbuyeva¶, Georgia Taylor¶, Todd Sherer¶, and J. Timothy Greenamyre¶

From the {ddagger}Carolinas Neuromuscular/ALS-MDA Center, Carolinas Medical Center, Charlotte, North Carolina 28203 and the Free Radicals in Medicine Core, §Division of Cardiology, Center for Neurodegenerative Disease, Emory University, Atlanta, Georgia 30322

Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4{Delta}{psi} of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.


Received for publication, August 5, 2005 , and in revised form, October 20, 2005.

* This work was supported by National Institutes of Health NIEHS Grant ES012068 and a grant from the Picower Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: 1000 Blythe Blvd., Charlotte, NC 28203. Tel.: 704-355-5902; Fax: 704-446-6255; E-mail: alexander.panov{at}carolinashealthcare.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
A. K. Doughan, D. G. Harrison, and S. I. Dikalov
Molecular Mechanisms of Angiotensin II-Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction
Circ. Res., February 29, 2008; 102(4): 488 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Watabe and T. Nakaki
Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Perez-Ortiz, P. Tranque, M. Burgos, C. F. Vaquero, and J. Llopis
Glitazones Induce Astroglioma Cell Death by Releasing Reactive Oxygen Species from Mitochondria: Modulation of Cytotoxicity by Nitric Oxide
Mol. Pharmacol., August 1, 2007; 72(2): 407 - 417.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. J.M. Janssen, F. J.M. Trijbels, R. C.A. Sengers, J. A.M. Smeitink, L. P. van den Heuvel, L. T.M. Wintjes, B. J.M. Stoltenborg-Hogenkamp, and R. J.T. Rodenburg
Spectrophotometric Assay for Complex I of the Respiratory Chain in Tissue Samples and Cultured Fibroblasts
Clin. Chem., April 1, 2007; 53(4): 729 - 734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Panov, S. Dikalov, N. Shalbuyeva, R. Hemendinger, J. T. Greenamyre, and J. Rosenfeld
Species- and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C708 - C718.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett Jr
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.
J. Neurosci., May 10, 2006; 26(19): 5256 - 5264.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.